SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (1005)11/9/1998 12:12:00 PM
From: Anthony Wong  Respond to of 1722
 
Centocor Inc. Reiterated 'Strong Buy' at Morgan Stanley DW

Bloomberg News
November 9, 1998, 11:15 a.m. ET

Princeton, New Jersey, Nov. 9 (Bloomberg Data) -- Centocor Inc. (CNTO US)
was reiterated ''strong buy'' by analyst Douglas D. Lind at Morgan Stanley
Dean Witter. The 12-month target price is $59.00 per share.

-- Andrew Bekoff in Princeton, New Jersey, (609)279-3652



To: Henry Niman who wrote (1005)11/9/1998 8:53:00 PM
From: Henry Niman  Read Replies (1) | Respond to of 1722
 
BioCognizance site at biocognizance.com is down again, but New Therapeutics page is linked to home.att.net